Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

• WITZIG TE

収録刊行物

• J Clin Oncol.

  J Clin Oncol. 20 2453-2463, 2002

詳細情報

• CRID: 1574231875324140928
• NII論文ID: 10021256830
• データソース種別:
  • CiNii Articles